April 18, 2019
FDA continues efforts to assess duodenoscope contamination risk
Editor's Note
The Food & Drug Administration (FDA) on April 12 announced that it is taking steps to implement additional regulatory actions, including consulting with federal health experts, on how to reduce the risks of contamination and infections linked to duodenoscopes.
The agency is also collaborating with manufacturers of disposable duodenoscopes that would make reprocessing unnecessary, and they are collaborating on new duodenoscope designs that may lower contamination risks.
Free Daily News
- JAMA video highlights OR sustainability
- AAP releases first opioid prescribing guidelines for children
- Hospitals urge federal action, move to mitigate storm, strike supply chain disruptions
- $350 million invested in medical gowns for Strategic National Stockpile
- FDA announces Class 1 recall for pediatric resuscitator
- GLP-1 agonists linked to food retention in EGD, but not combined EGD-colonoscopy
- Healthcare employment up in September
- World's first all-plastic ankle replacement offers hope for patients with metal allergies
- AAMI, CTA partners to develop healthcare AI standards
- ECRI issues guidance to address medical supply shortages caused by Hurricane Helene, dockworkers’ strike
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement